- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pegylated Liposomal Doxorubicin (PLD)
Total 1216 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | t(9;22) | BCR-ABL1 Fusion Protein ExpressionUnited States
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-LikeUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Fallopian Tube Carcinoma | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingDown Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States, Puerto Rico, Australia, Canada, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Lymphoblastic Lymphoma | Mixed Phenotype Acute LeukemiaUnited States, Canada, Australia, Puerto Rico, New Zealand
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Ph-Like Acute Lymphoblastic Leukemia | Refractory Ph-Like Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingNeuroblastoma | GanglioneuroblastomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBlastic Plasmacytoid Dendritic Cell NeoplasmUnited States
-
National Cancer Institute (NCI)Not yet recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
National Cancer Institute (NCI)Not yet recruiting
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel